Lamont, David
Department of Diabetes & Endocrinology
CSL Behring
Austria
Biography
David Lamont was appointed as Chief Financial Officer in January 2016. As Chief Financial Officer, he is responsible for managing the financial aspects of CSL’s strategy which includes financial planning and reporting, capital management, tax, treasury and investor relations. David holds a Bachelor of Commerce degree and is a qualified Chartered Accountant and a member of the Institute of Chartered Accountants (Australia).
Research Interest
Research, Pharmaceuticals, Biotechnology, Healthcare, Medical Science
